Pediatrix Medical Group (Pediatrix Medical Group) Change In Receivables : $26 Mil (TTM As of Dec. 2023)

View and export this data going back to 1959. Start your Free Trial

What is Pediatrix Medical Group Change In Receivables?

Pediatrix Medical Group's change in receivables for the quarter that ended in Dec. 2023 was $4 Mil. It means Pediatrix Medical Group's Accounts Receivable declined by $4 Mil from Sep. 2023 to Dec. 2023 .

Pediatrix Medical Group's change in receivables for the fiscal year that ended in Dec. 2023 was $26 Mil. It means Pediatrix Medical Group's Accounts Receivable declined by $26 Mil from Dec. 2022 to Dec. 2023 .

Pediatrix Medical Group's Accounts Receivable for the quarter that ended in Dec. 2023 was $272 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Pediatrix Medical Group's Days Sales Outstanding for the three months ended in Dec. 2023 was 50.05.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Pediatrix Medical Group's liquidation value for the three months ended in Dec. 2023 was $-989 Mil.

Pediatrix Medical Group Change In Receivables Historical Data

The historical data trend for Pediatrix Medical Group's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pediatrix Medical Group Change In Receivables Chart

Pediatrix Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-17.61

31.01

-72.73

-5.54

26.28

Pediatrix Medical Group Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-5.04	21.35	7.56	-6.81	4.18

Pediatrix Medical Group Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $26 Mil.

Pediatrix Medical Group (NYSE:MD) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Pediatrix Medical Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	272.313	/	496.443	*	91
=	50.05

2. In Ben Graham's calculation of liquidation value, Pediatrix Medical Group's accounts receivable are only considered to be worth 75% of book value:

Pediatrix Medical Group's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	177.743	-	1370.749	+	0.75 * 272.313	+	0.5 * 0
=	-989

Pediatrix Medical Group Change In Receivables Related Terms

Thank you for viewing the detailed overview of Pediatrix Medical Group's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Pediatrix Medical Group (Pediatrix Medical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pediatrix Medical Group Inc (NYSE:MD) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

MD:Mexico PDC:Germany

Address

1301 Concord Terrace, Sunrise, FL, USA, 33323

Website

https://www.pediatrix.com

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment, which is physician services. The company generates roughly half of its revenue from the women's and children's services provided, and also roughly half of the company's total revenue is earned in the United States.

Executives

James D Swift	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Moore Mary Ann E	officer: EVP Chief ERM/Legal Ops Off	1301 CONCORD TERRACE, SUNRISE FL 33323
Mark S Ordan	director, officer: Chief Executive Officer	7315 WISCONSIN AVENUE, SUITE #250 WEST, BETHESDA MD 20814
Shirley A Weis	director	11621 RESEARCH CIRCLE, GAINESVILLE FL 32615
Sylvia Jean Young	director	C/O LINCOLN EDUCATIONAL SERVICES CORPORA, 14 SYLVAN WAY, STE. A, PARSIPPANY NJ 07054
Lee Wood	officer: EVP, Natl & Market Operations	1301 CONCORD TERRACE, SUNRISE FL 33323
Curtis Pickert	officer: EVP, Chief Operating Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Laura A Linynsky	director	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Md Medel	director, officer: PRES. & CHIEF EXEC. OFFICER	1301 CONCORD TERRACE, SUNRISE FL 33323
John C Pepia	officer: Principal Accounting Officer	1301 CONCORD TERRACE, SUNRISE FL 33323
Roger Mack Hinson	officer: Pres., PDX & OBX Medical Group	C/O MEDNAX, INC., 1301 CONCORD TERRACE, SUNRISE FL 33323
C Marc Richards	officer: EVP, Chief Financial Officer	7315 WISCONSIN AVENUE, SUITE 250-W, BETHESDA MD 20814
Dominic J Andreano	officer: Sr.VP,General Counsel & Secy.	1301 CONCORD TERRACE, SUNRISE FL 33323
Nicholas Nikolopoulos	officer: EVP Chf Strategy & Growth Offi	MEDNAX INC, 1301, SUNRISE FL 33323
Guy P Sansone	director	C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323